• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤发生的药物靶点:来自表皮生长因子受体(EGFR)信号网络结构分析的见解

Drug targets for tumorigenesis: insights from structural analysis of EGFR signaling network.

作者信息

Durmuş Tekir Saliha, Yalçin Arga Kazim, Ulgen Kutlu O

机构信息

Department of Chemical Engineering, Boğaziçi University, 34342 Bebek-Istanbul, Turkey.

出版信息

J Biomed Inform. 2009 Apr;42(2):228-36. doi: 10.1016/j.jbi.2008.08.008. Epub 2008 Aug 26.

DOI:10.1016/j.jbi.2008.08.008
PMID:18790083
Abstract

Deciphering the complex network structure is crucial in drug target identification. This study presents a framework incorporating graph theoretic and network decomposition methods to analyze system-level properties of the comprehensive map of the epidermal growth factor receptor (EGFR) signaling, which is a good candidate model system to study the general mechanisms of signal transduction. The graph theoretic analysis of the EGFR network indicates that it has small-world characteristics with scale-free topology. The employment of network decomposition analysis enlightened the system-level properties, such as network cross-talk, specific molecules in each pathway and participation of molecules in the network. Participating in a significant fraction of the fundamental paths connecting the ligands to the phenotypes, cofactor GTP and complex Gbeta/Ggamma were identified as "housekeeping" molecules, through which all pathways of EGFR network are cross-talking. c-Src-Shc complex is identified as important due to its role in all fundamental paths through tumorigenesis and being specific to this phenotype. Inhibitors of this complex may be good anti-cancer agents having very little or no effect on other phenotypes.

摘要

破译复杂的网络结构对于药物靶点识别至关重要。本研究提出了一个结合图论和网络分解方法的框架,用于分析表皮生长因子受体(EGFR)信号通路综合图谱的系统级特性,EGFR信号通路是研究信号转导一般机制的良好候选模型系统。对EGFR网络的图论分析表明,它具有无标度拓扑的小世界特征。网络分解分析的应用揭示了系统级特性,如网络串扰、各通路中的特定分子以及分子在网络中的参与情况。辅因子GTP和复合物Gbeta/Ggamma参与了连接配体与表型的大部分基本通路,被确定为“管家”分子,EGFR网络的所有通路都通过它们进行串扰。c-Src-Shc复合物因其在所有通过肿瘤发生的基本通路中的作用以及对该表型的特异性而被确定为重要分子。该复合物的抑制剂可能是对其他表型影响很小或没有影响的良好抗癌药物。

相似文献

1
Drug targets for tumorigenesis: insights from structural analysis of EGFR signaling network.肿瘤发生的药物靶点:来自表皮生长因子受体(EGFR)信号网络结构分析的见解
J Biomed Inform. 2009 Apr;42(2):228-36. doi: 10.1016/j.jbi.2008.08.008. Epub 2008 Aug 26.
2
Targeting the EGFR and the PKB pathway in cancer.针对癌症中的表皮生长因子受体(EGFR)和蛋白激酶B(PKB)信号通路
Curr Opin Cell Biol. 2009 Apr;21(2):185-93. doi: 10.1016/j.ceb.2008.12.006. Epub 2009 Feb 11.
3
A mathematical model of combination therapy using the EGFR signaling network.一种使用表皮生长因子受体(EGFR)信号网络的联合治疗数学模型。
Biosystems. 2005 Apr;80(1):57-69. doi: 10.1016/j.biosystems.2004.10.002.
4
Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention.环氧化酶-2与表皮生长因子受体:化学预防的药理学靶点
J Clin Oncol. 2005 Jan 10;23(2):254-66. doi: 10.1200/JCO.2005.09.112.
5
Epidermal growth factor receptor inhibitors in cancer treatment: advances, challenges and opportunities.癌症治疗中的表皮生长因子受体抑制剂:进展、挑战与机遇
Anticancer Drugs. 2009 Nov;20(10):851-5. doi: 10.1097/CAD.0b013e3283330590.
6
Proteins, drug targets and the mechanisms they control: the simple truth about complex networks.蛋白质、药物靶点及其控制的机制:关于复杂网络的简单真相。
Nat Rev Drug Discov. 2007 Nov;6(11):871-80. doi: 10.1038/nrd2381.
7
Potential for molecularly targeted therapy against epidermal growth factor receptor ligands.针对表皮生长因子受体配体的分子靶向治疗潜力。
Anticancer Res. 2009 Mar;29(3):823-30.
8
Cracking the mild, difficult and fiendish codes within and downstream of the EGFR to link diagnostics and therapeutics.破解表皮生长因子受体(EGFR)及其下游的轻度、困难和极其困难的编码,以连接诊断和治疗。
Biochem Soc Trans. 2007 Feb;35(Pt 1):1-6. doi: 10.1042/BST0350001.
9
Robustness analysis of EGFR signaling network with a multi-objective evolutionary algorithm.基于多目标进化算法的表皮生长因子受体(EGFR)信号网络稳健性分析
Biosystems. 2008 Jan;91(1):245-61. doi: 10.1016/j.biosystems.2007.10.001. Epub 2007 Oct 23.
10
Mutations and response to epidermal growth factor receptor inhibitors.突变与对表皮生长因子受体抑制剂的反应
Clin Cancer Res. 2009 Feb 15;15(4):1133-9. doi: 10.1158/1078-0432.CCR-08-0905.

引用本文的文献

1
Reconstruction and analysis of a large-scale binary Ras-effector signaling network.重建和分析大规模的二元 Ras 效应子信号网络。
Cell Commun Signal. 2022 Mar 4;20(1):24. doi: 10.1186/s12964-022-00823-5.
2
Effects of ordered mutations on dynamics in signaling networks.有序突变对信号网络动力学的影响。
BMC Med Genomics. 2020 Feb 20;13(Suppl 4):13. doi: 10.1186/s12920-019-0651-z.
3
The role of protein interaction networks in systems biomedicine.蛋白质相互作用网络在系统生物医学中的作用。
Comput Struct Biotechnol J. 2014 Sep 3;11(18):22-7. doi: 10.1016/j.csbj.2014.08.008. eCollection 2014 Aug.
4
A network-based approach on elucidating the multi-faceted nature of chronological aging in S. cerevisiae.基于网络的方法阐明酿酒酵母中时间相关衰老的多方面性质。
PLoS One. 2011;6(12):e29284. doi: 10.1371/journal.pone.0029284. Epub 2011 Dec 21.
5
Reconstruction of protein-protein interaction network of insulin signaling in Homo sapiens.人类胰岛素信号传导的蛋白质-蛋白质相互作用网络的重建
J Biomed Biotechnol. 2010;2010:690925. doi: 10.1155/2010/690925. Epub 2010 Dec 14.
6
Network analyses in systems pharmacology.系统药理学中的网络分析。
Bioinformatics. 2009 Oct 1;25(19):2466-72. doi: 10.1093/bioinformatics/btp465. Epub 2009 Jul 30.